Results 101 to 110 of about 209,031 (375)

Integrating sex and gender in studies of cardiac resynchronization therapy: a systematic review [PDF]

open access: gold, 2021
Omar Dewidar   +7 more
openalex   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher   +12 more
wiley   +1 more source

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

open access: yesEuropean Heart Journal, 2021
M. Glikson   +23 more
semanticscholar   +2 more sources

Machine learning‐based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy

open access: yesEuropean Journal of Heart Failure, 2018
We tested the hypothesis that a machine learning (ML) algorithm utilizing both complex echocardiographic data and clinical parameters could be used to phenogroup a heart failure (HF) cohort and identify patients with beneficial response to cardiac ...
M. Čikeš   +13 more
semanticscholar   +1 more source

Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1227-1236, April 2025.
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch   +8 more
wiley   +1 more source

Ressincronização cardíaca em doente com transposição congenitamente corrigida das grandes artérias

open access: yesRevista Portuguesa de Cardiologia, 2014
Resumo: A transposição congenitamente corrigida das grandes artérias é uma cardiopatia rara associada a disfunção do ventrículo sistémico e perturbações da condução.A utilização de terapia de ressincronização cardíaca em doentes com cardiopatia congénita
Pedro Alexandre Sousa   +6 more
doaj   +1 more source

Outcomes of Cardiac Resynchronization Therapy in Patients with Hypothyroidism and Heart Failure

open access: yesBMC Cardiovascular Disorders, 2020
Background Hypothyroidism is known to be associated with adverse clinical outcomes in heart failure. The association between hypothyroidism and cardiac resynchronization therapy outcomes in patients with severe heart failure is not clear.
Mei Yang   +7 more
doaj   +1 more source

Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients

open access: yesESC Heart Failure, 2021
Aims The implantable cardiac defibrillator/cardiac resynchronization therapy with defibrillator‐based HeartLogic™ algorithm has recently been developed for early detection of impending decompensation in heart failure (HF) patients; but whether this novel
Roderick W. Treskes   +14 more
doaj   +1 more source

Long-term cerebral thromboembolic complications of transapical endocardial resynchronization therapy [PDF]

open access: yes, 2017
Purpose: Cardiac resynchronization therapy (CRT) is an established therapeutic option in selected heart failure patients (pts). However, the transvenous left ventricular (LV) lead implantation remains ineffectual in a considerable number of pts ...
Arany, A. (Andrea)   +7 more
core   +2 more sources

Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1479-1484, April 2025.
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy